Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM; IMAGE Investigators.

Ann Rheum Dis. 2011 Jan;70(1):39-46. doi: 10.1136/ard.2010.137703. Epub 2010 Oct 11.

PMID:
20937671
2.

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis.

Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.

Ann Rheum Dis. 2011 Feb;70(2):266-71. doi: 10.1136/ard.2010.132134. Epub 2010 Nov 19. Review. Erratum in: Ann Rheum Dis. 2011 Mar;70(3):560.

PMID:
21097801
3.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.

PMID:
19917618
4.

B-cell therapies in established rheumatoid arthritis.

Leandro MJ, Becerra-Fernandez E.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):535-48. doi: 10.1016/j.berh.2011.10.005. Review.

PMID:
22137923
5.

Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.

Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J.

Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Review.

PMID:
18823645
6.

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.

Lee YH, Bae SC, Song GG.

Rheumatol Int. 2011 Nov;31(11):1493-9. doi: 10.1007/s00296-010-1526-y. Epub 2010 May 16. Review.

PMID:
20473756
7.

Treatment of early rheumatoid arthritis: concepts in management.

Haraoui B, Pope J.

Semin Arthritis Rheum. 2011 Apr;40(5):371-88. doi: 10.1016/j.semarthrit.2010.10.004. Epub 2011 Feb 4. Review.

PMID:
21295822
8.

[Paradigm shift and future perspectives in rheumatoid arthritis].

Miyasaka N.

Nihon Rinsho. 2013 Jul;71(7):1141-6. Review. Japanese.

PMID:
23961658
9.
10.

Developing an effective treatment algorithm for rheumatoid arthritis.

Keystone EC, Smolen J, van Riel P.

Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v48-54. doi: 10.1093/rheumatology/kes122. Review.

PMID:
22718927
11.

Combination therapy in early rheumatoid arthritis.

Gossec L, Dougados M.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S174-8. Review.

PMID:
14969072
12.

Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, Dougados M, Ferraccioli G, Jaeger U, Klareskog L, Kvien TK, Martin-Mola E, Pavelka K; Working Group on the Rituximab Consensus Statement.

Ann Rheum Dis. 2007 Feb;66(2):143-50. Epub 2006 Oct 26.

13.

[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ].

Martín Mola E, Hernández B, García-Arias M, Alvaro-Gracia JM, Balsa A, Reino JG, Marenco de la Fuente JL, Martínez-Taboada V, Ivorra JA, Sanmartí R; el grupo de Expertos en Rituximab.

Reumatol Clin. 2011 Jan-Feb;7(1):30-44. doi: 10.1016/j.reuma.2010.11.002. Epub 2010 Dec 17. Spanish.

14.

Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link?

van Sijl AM, van der Weele W, Nurmohamed MT.

Curr Pharm Des. 2014;20(4):496-9. Review.

PMID:
23565629
15.

Rituximab-it was the best of times, it was the worst of times.

Isenberg DA.

Autoimmun Rev. 2012 Sep;11(11):790-1. doi: 10.1016/j.autrev.2012.02.005. Epub 2012 Feb 12. Review.

PMID:
22349619
16.

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P; Rituximab Consensus Expert Committee.

Ann Rheum Dis. 2011 Jun;70(6):909-20. doi: 10.1136/ard.2010.144998. Epub 2011 Mar 6.

17.

[Pharmacological approaches in immuno-rhumatology].

Fabre S.

Therapie. 2011 Sep-Oct;66(5):397-404. doi: 10.2515/therapie/2011063. Epub 2011 Oct 27. Review. French.

PMID:
22031683
18.

Treatment of pseudo Felty's syndrome: Is there a place for rituximab?

Verhoeven F, Guillot X, Prati C, Wendling D.

Joint Bone Spine. 2015 May;82(3):196-9. doi: 10.1016/j.jbspin.2014.12.001. Epub 2015 Jan 23. Review.

PMID:
25623522
19.

Progress toward personalized treatment of rheumatoid arthritis.

Keith MP, Edison JD, Gilliland WR.

Clin Pharmacol Ther. 2012 Oct;92(4):440-2. doi: 10.1038/clpt.2012.124. Epub 2012 Aug 22. Review.

PMID:
22910444
20.

Supplemental Content

Support Center